UGRP CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. UGRP Gen Silencer sind erhältlich als UGRP CRISPR/Cas9 Knockout Plasmide und UGRP Double Nickase Plasmide. UGRP CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
UGRP CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
UGRP1 CRISPR/Cas9 KO Plasmid (h) | sc-416243 | h | Gene Knockout | GFP | 0 | ||
UGRP1 HDR Plasmid (h) | sc-416243-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
UGRP1 Double Nickase Plasmid (h) | sc-416243-NIC | h | Gene Knockout | Puromycin | 0 | ||
UGRP1 Double Nickase Plasmid (h2) | sc-416243-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
UGRP1 CRISPR/Cas9 KO Plasmid (m) | sc-431180 | m | Gene Knockout | GFP | 0 | ||
UGRP1 HDR Plasmid (m) | sc-431180-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
UGRP1 Double Nickase Plasmid (m) | sc-431180-NIC | m | Gene Knockout | Puromycin | 0 | ||
UGRP1 Double Nickase Plasmid (m2) | sc-431180-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
UGRP2 CRISPR/Cas9 KO Plasmid (h) | sc-413939 | h | Gene Knockout | GFP | 0 | ||
UGRP2 HDR Plasmid (h) | sc-413939-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
UGRP2 Double Nickase Plasmid (h) | sc-413939-NIC | h | Gene Knockout | Puromycin | 0 | ||
UGRP2 Double Nickase Plasmid (h2) | sc-413939-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
UGRP2 CRISPR/Cas9 KO Plasmid (m) | sc-427132 | m | Gene Knockout | GFP | 0 | ||
UGRP2 HDR Plasmid (m) | sc-427132-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
UGRP2 Double Nickase Plasmid (m) | sc-427132-NIC | m | Gene Knockout | Puromycin | 0 | ||
UGRP2 Double Nickase Plasmid (m2) | sc-427132-NIC-2 | m | Gene Knockout | Puromycin | 0 |
UGRP CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
UGRP1 CRISPR Activation Plasmid (h) | sc-416243-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP1 CRISPR Activation Plasmid (h2) | sc-416243-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP1 Lentiviral Activation Particles (h) | sc-416243-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP1 Lentiviral Activation Particles (h2) | sc-416243-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP1 CRISPR Activation Plasmid (m) | sc-431180-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP1 CRISPR Activation Plasmid (m2) | sc-431180-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP1 Lentiviral Activation Particles (m) | sc-431180-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP1 Lentiviral Activation Particles (m2) | sc-431180-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 CRISPR Activation Plasmid (h) | sc-413939-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 CRISPR Activation Plasmid (h2) | sc-413939-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 Lentiviral Activation Particles (h) | sc-413939-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 Lentiviral Activation Particles (h2) | sc-413939-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 CRISPR Activation Plasmid (m) | sc-427132-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 CRISPR Activation Plasmid (m2) | sc-427132-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 Lentiviral Activation Particles (m) | sc-427132-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
UGRP2 Lentiviral Activation Particles (m2) | sc-427132-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |